Mechanism involved in enhancement of osteoblast differentiation by hyaluronic acid

Biochemical and Biophysical Research Communications

Volumn 405, Issue 4, 2011, Pages 575-580

  Kawano, Michinao ^a   Ariyoshi, Wataru ^a   Iwanaga, Kenjiro ^a   Okinaga, Toshinori ^a   Habu, Manabu ^a   Yoshioka, Izumi ^b   Tominaga, Kazuhiro ^a   Nishihara, Tatsuji ^a  

^a KYUSHU DENTAL COLLEGE   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

ALP; BMP 2; Hyaluronic acid; MAPK; Osteoblast; Smad

Indexed keywords

ALKALINE PHOSPHATASE; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; DERMATAN SULFATE; FOLLISTATIN; HEPARAN SULFATE; HEPARIN; HYALURONIC ACID; KERATAN SULFATE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NOGGIN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; CELL DIFFERENTIATION; CELL LYSATE; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INCUBATION TIME; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ACTIVE TRANSPORT, CELL NUCLEUS; BONE MORPHOGENETIC PROTEIN 2; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL LINE; DOWN-REGULATION; FOLLISTATIN; HUMANS; HYALURONIC ACID; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OSTEOBLASTS; OSTEOGENESIS; PHOSPHORYLATION; RNA, MESSENGER; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

EID: 79951946786     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.071     Document Type: Article

References (43)

1. Knudson C.B., Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J. 1993, 7:1233-1241.
2. Lee J.Y., Spicer A.P. Hyaluronan: a multifunctional, megaDalton, stealth molecule. Curr. Opin. Cell Biol. 2000, 12:581-586.
3. Clarris B.J., Fraser J.R. On the pericellular zone of some mammalian cells in vitro. Exp. Cell Res. 1968, 49:181-193.
4. Goldberg R.L., Toole B.P. Pericellular coat of chick embryo chondrocytes: structural role of hyaluronate. J. Cell Biol. 1984, 99:2114-2122.
5. Heldin P., Pertoft H. Synthesis and assembly of the hyaluronan-containing coats around normal human mesothelial cells. Exp. Cell Res. 1993, 208:422-429.
6. Knudson C.B., Toole B.P. Changes in the pericellular matrix during differentiation of limb bud mesoderm. Dev. Biol. 1985, 112:308-318.
7. Knudson W., Knudson C.B. Assembly of a chondrocyte-like pericellular matrix on non-chondrogenic cells. Role of the cell surface hyaluronan receptors in the assembly of a pericellular matrix. J. Cell Sci. 1991, 99(Pt. 2):227-235.
8. McGuire P.G., Castellot J.J., Orkin R.W. Size-dependent hyaluronate degradation by cultured cells. J. Cell. Physiol. 1987, 133:267-276.
9. Underhill C.B., Toole B.P. Transformation-dependent loss of the hyaluronate-containing coats of cultured cells. J. Cell. Physiol. 1982, 110:123-128.
10. Fujii Y., Fujii K., Nakano K., Tanaka Y. Crosslinking of CD44 on human osteoblastic cells upregulates ICAM-1 and VCAM-1. FEBS Lett. 2003, 539:45-50.
11. Yamazaki M., Nakajima F., Ogasawara A., Moriya H., Majeska R.J., Einhorn T.A. Spatial and temporal distribution of CD44 and osteopontin in fracture callus. J. Bone Joint Surg. Br. 1999, 81:508-515.
12. Spessotto P., Rossi F.M., Degan M., Di Francia R., Perris R., Colombatti A., Gattei V. Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J. Cell Biol. 2002, 158:1133-1144.
13. Sterling H., Saginario C., Vignery A. CD44 occupancy prevents macrophage multinucleation. J. Cell Biol. 1998, 143:837-847.
14. Pavasant P., Shizari T.M., Underhill C.B. Distribution of hyaluronan in the epiphysial growth plate: turnover by CD44-expressing osteoprogenitor cells. J. Cell Sci. 1994, 107(Pt. 10):2669-2677.
15. Urist M.R. Bone: formation by autoinduction. Science 1965, 150:893-899.
16. Canalis E., Economides A.N., Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr. Rev. 2003, 24:218-235.
17. Wrana J.L. Regulation of Smad activity. Cell 2000, 100:189-192.
18. Waite K.A., Eng C. From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family. Nat. Rev. Genet. 2003, 4:763-773.
19. Ito Y., Miyazono K. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr. Opin. Genet. Dev. 2003, 13:43-47.
20. Kanzaki S., Takahashi T., Kanno T., Ariyoshi W., Shinmyouzu K., Tujisawa T., Nishihara T. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor. J. Cell. Physiol. 2008, 216:844-850.
21. Meran S., Thomas D.W., Stephens P., Enoch S., Martin J., Steadman R., Phillips A.O. Hyaluronan facilitates transforming growth factor-beta1-mediated fibroblast proliferation. J. Biol. Chem. 2008, 283:6530-6545.
22. Andhare R.A., Takahashi N., Knudson W., Knudson C.B. Hyaluronan promotes the chondrocyte response to BMP-7. Osteoarthritis Cartilage 2009, 17:906-916.
23. Rasmussen T., Uttenthal A., De Stricker K., Belak S., Storgaard T. Development of a novel quantitative real-time RT-PCR assay for the simultaneous detection of all serotypes of foot-and-mouth disease virus. Arch. Virol. 2003, 148:2005-2021.
24. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29:e45.
25. Hoffmann A., Gross G. BMP signaling pathways in cartilage and bone formation. Crit. Rev. Eukaryot. Gene Expr. 2001, 11:23-45.
26. Suzawa M., Takeuchi Y., Fukumoto S., Kato S., Ueno N., Miyazono K., Matsumoto T., Fujita T. Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro. Endocrinology 1999, 140:2125-2133.
27. Itano N., Atsumi F., Sawai T., Yamada Y., Miyaishi O., Senga T., Hamaguchi M., Kimata K. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc. Natl. Acad. Sci. USA 2002, 99:3609-3614.
28. Rochman M., Moll J., Herrlich P., Wallach S.B., Nedvetzki S., Sionov R.V., Golan I., Ish-Shalom D., Naor D. The CD44 receptor of lymphoma cells: structure-function relationships and mechanism of activation. Cell Adhes. Commun. 2000, 7:331-347.
29. Naor D., Nedvetzki S. CD44 in rheumatoid arthritis. Arthritis Res. Ther. 2003, 5:105-115.
30. Nedvetzki S., Gonen E., Assayag N., Reich R., Williams R.O., Thurmond R.L., Huang J.F., Neudecker B.A., Wang F.S., Turley E.A., Naor RHAMM D. A receptor for hyaluronan-mediated motility, compensates for CD44in inflamed CD44-knockout mice: a different interpretation of redundancy. Proc. Natl. Acad. Sci. USA 2004, 101:18081-18086.
31. Selbi W., Day A.J., Rugg M.S., Fulop C., de la Motte C.A., Bowen T., Hascall V.C., Phillips A.O. Overexpression of hyaluronan synthase 2 alters hyaluronan distribution and function in proximal tubular epithelial cells. J. Am. Soc. Nephrol. 2006, 17:1553-1567.
32. Selbi W., de la Motte C.A., Hascall V.C., Day A.J., Bowe T., Phillips A.O. Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney Int. 2006, 70:1287-1295.
33. Knudson W., Aguiar D.J., Hua Q., Knudson C.B. CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis. Exp. Cell Res. 1996, 228:216-228.
34. Knudson W., Chow G., Knudson C.B. CD44-mediated uptake and degradation of hyaluronan. Matrix Biol. 2002, 21:15-23.
35. Heldin C.H., Miyazono K., ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997, 390:465-471.
36. Winkler D., Sutherland M., Geoghegan J., Yu C., Hayes T., Skonier J., Shpektor D., Jonas M., Kovacevich B., Staehling-Hampton K. Osteocyte control of bone formation via sclerostin, a novel BMP antagonist. EMBO J. 2003, 22:6267-6276.
37. Rosen V. BMP and BMP inhibitors in bone. Ann. N. Y. Acad. Sci. 2006, 1068:19-25.
38. Xiao Y., Xiang L., Shao J. Bone morphogenetic protein. Biochem. Biophys. Res. Commun. 2007, 362:550-553.
39. Matzuk M.M., Lu N., Vogel H., Sellheyer K., Roop D.R., Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature 1995, 374:360-363.
40. Shibanuma M., Mashimo J., Mita A., Kuroki T., Nose K. Cloning from a mouse osteoblastic cell line of a set of transforming-growth-factor-beta 1-regulated genes, one of which seems to encode a follistatin-related polypeptide. Eur. J. Biochem. 1993, 217:13-19.
41. Zhang Y.Q., Kanzaki M., Shibata H., Kojima I. Regulation of the expression of follistatin in rat hepatocytes. Biochim. Biophys. Acta 1997, 1354:204-210.
42. Fuentealba L.C., Eivers E., Ikeda A., Hurtado C., Kuroda H., Pera E.M., De Robertis E.M. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 2007, 131:980-993.
43. Elshaier A.M., Hakimiyan A.A., Rappoport L., Rueger D.C., Chubinskaya S. Effect of interleukin-1beta on osteogenic protein 1-induced signaling in adult human articular chondrocytes. Arthritis Rheum. 2009, 60:143-154.